Overview
Elizabeth Raetz is a Hematologist and an Oncologist practicing medicine in Salt Lake City, Utah.
Dr. Raetz is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Dr. Raetz is board certified in American Board Of Pediatrics. She is actively involved in clinical research, co-authoring 200 peer reviewed articles and participating in 4 clinical trials. Dr. Raetz is currently accepting new patients.
Specialties
Licenses
Board Certifications
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
Locations
100 N Mario Capecchi Dr, Salt Lake City, UT 84113
Additional Areas of Focus
Dr. Raetz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
University Of Utah Hospital Services
Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics. Dr. Pulsipher is currently accepting new patients.
Huntsman Cancer Institute, Univ. Of Utah
Narendranath Epperla is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Epperla is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Epperla is board certified in American Board Of Internal Medicine. Dr. Epperla is currently accepting new patients.
Univ. Of Utah Hosp. Im-Hematology-Hematologic
Josef Prchal is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Prchal is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant. Dr. Prchal is board certified in American Board Of Internal Medicine. Dr. Prchal is currently accepting new patients.
Frequently Asked Questions about Dr. Elizabeth A. Raetz
How do I make an appointment with Dr. Elizabeth A. Raetz?
You can book an appointment with Dr. Elizabeth A. Raetz by calling their office at 801-662-4700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Elizabeth A. Raetz a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth A. Raetz is classified as an Elite expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Elizabeth A. Raetz specialize in?
While Dr. Elizabeth A. Raetz is a Hematology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Leukemia, and Adult T-Cell Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Elizabeth A. Raetz participate in research or clinical trials?
Yes. Dr. Elizabeth A. Raetz has published 200 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Elizabeth A. Raetz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Elizabeth A. Raetz accept my insurance?
Dr. Elizabeth A. Raetz accepts most major insurance plans, including Anthem BCBS and Cigna. We recommend calling the office directly at 801-662-4700 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Lymphoblastic Leukemia (ALL)
- Adult T-Cell LeukemiaDr. Raetz isElite. Learn about Adult T-Cell Leukemia.
- LeukemiaDr. Raetz isElite. Learn about Leukemia.
- Advanced
- AgranulocytosisDr. Raetz isAdvanced. Learn about Agranulocytosis.
- Childhood Acute Myeloid Leukemia
- Kienbock's DiseaseDr. Raetz isAdvanced. Learn about Kienbock's Disease.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Raetz isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Raetz isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Raetz isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Raetz isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaDr. Raetz isExperienced. Learn about Burkitt Lymphoma.
- Chronic Myelogenous Leukemia (CML)Dr. Raetz isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Ewing SarcomaDr. Raetz isExperienced. Learn about Ewing Sarcoma.
- Non-Hodgkin LymphomaDr. Raetz isExperienced. Learn about Non-Hodgkin Lymphoma.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- RUNX1 Familial Platelet DisorderDr. Raetz isExperienced. Learn about RUNX1 Familial Platelet Disorder.
